Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
CMC Biologics
CMC Biologics
Activities:
Manufacturing
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Fasenra for EGPA: addressing unmet needs
Benralizumab could offer patients with EGPA more treatment options, while reducing dependency on oral corticosteroids
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities
Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Manufacturing
CMC Biologics to manufacture bispecific antibodies for F-star
Supporting F-star’s strong pipeline development in immuno-oncology
Manufacturing
CMC Biologics and IDT Biologika collaborate to manufacture antibody drug conjugates
Alliance will provide an efficient end-to-end solution for the development and manufacture of ADCs
Research & Development
CMC Biologics and PATH MVI to develop monoclonal antibodies to treat malaria
Manufacture of monoclonal antibodies to the malaria parasite scheduled for CMC’s Berkeley, US, facility
Manufacturing
CMC Biologics expands GMP manufacturing capacity in the US
Bioreactor 6Pack facility provides flexible solutions for Phase III and commercial production
Manufacturing
CMC Biologics adds capacity to GMP manufacturing facility in Denmark
Bioreactor 6Pack facility design provides flexible solutions for Phase III and commercial production
Manufacturing
CMC Biologics makes two appointments
Mark Sawicki and Patricio Massera join the CRO
Manufacturing
CMC Biologics and Inspiration agree supply of IB1001
For the treatment and prevention of bleeding in haemophilia B patients
Subscribe now